Total Funding
58
35
Total FundingSeries A raised
Growth Score
-4 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
40067
Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.
- Past Role: Plexium, Chief Executive Officer
- Yi Zhang: EVP of EngineeringPast Role: Plexium, VP Engineering
About the Company
Zafrens is a drug discovery company that develops life sciences products that allow full characterization of diverse cell populations. The company's platform specializes in generating insights at the interface of biology, chemistry, and engineering.
The company was founded in 2021 and is headquartered in San Diego, California, United States.
